• Thu, August 1, 2024

by: WOPRAI

Sanjay Sakhrani Maintained (AVDX) at Hold with Decreased Target to $11 on, Aug 1st, 2024

by: WOPRAI

Andrew Bauch Maintained (AVDX) at Hold with Decreased Target to $10 on, Aug 1st, 2024

by: WOPRAI

Clarke Jeffries Maintained (AVDX) at Hold with Decreased Target to $9 on, Aug 1st, 2024

by: WOPRAI

Rufus Hone Maintained (AVDX) at Hold with Decreased Target to $10 on, Aug 1st, 2024

by: WOPRAI

Will Nance Maintained (AVDX) at Strong Sell with Decreased Target to $9 on, Aug 1st, 2024

by: WOPRAI

Josh Beck Maintained (AVDX) at Buy with Decreased Target to $12 on, Aug 1st, 2024

by: WOPRAI

Joseph Pantginis Reiterated (atyr) at Strong Buy and Held Target at $35 on, Aug 1st, 2024

by: WOPRAI

Hans Mosesmann Maintained (ARM) at Strong Buy and Held Target at $180 on, Aug 1st, 2024

by: WOPRAI

Charles Shi Reiterated (ARM) at Hold on, Aug 1st, 2024

by: WOPRAI

Blayne Curtis Maintained (ARM) at Buy with Increased Target to $125 on, Aug 1st, 2024

by: WOPRAI

Mark Lipacis Maintained (ARM) at Buy with Increased Target to $173 on, Aug 1st, 2024

by: WOPRAI

Ross Seymore Maintained (ARM) at Hold with Increased Target to $105 on, Aug 1st, 2024

by: WOPRAI

Matthew Ramsay Maintained (ARM) at Strong Buy with Increased Target to $150 on, Aug 1st, 2024

by: WOPRAI

Andrew Gardiner Maintained (ARM) at Strong Buy with Increased Target to $170 on, Aug 1st, 2024

by: WOPRAI

Andrew Fein Reiterated (ARVN) at Strong Buy and Held Target at $87 on, Aug 1st, 2024

by: WOPRAI

Ami Fadia Reiterated (BIIB) at Strong Buy and Held Target at $288 on, Aug 1st, 2024

by: WOPRAI

Thomas Palmer Downgraded (BG) to Hold and Decreased Target to $114 on, Aug 1st, 2024

by: WOPRAI

Darrin Peller Downgraded (BILL) to Hold on, Aug 1st, 2024

by: WOPRAI

David Saxon Reiterated (BLCO) at Hold on, Aug 1st, 2024

by: WOPRAI

Douglas Miehm Reiterated (BLCO) at Buy and Held Target at $20 on, Aug 1st, 2024

by: WOPRAI

Pito Chickering Maintained (BLCO) at Hold with Increased Target to $18 on, Aug 1st, 2024

by: WOPRAI

Rob Oliver Maintained (BLKB) at Buy with Increased Target to $92 on, Aug 1st, 2024

by: WOPRAI

Robert Burns Reiterated (BNTX) at Strong Buy and Held Target at $113 on, Aug 1st, 2024

by: WOPRAI

Joseph Pantginis Reiterated (BNOX) at Strong Buy and Held Target at $8 on, Aug 1st, 2024

by: WOPRAI

Mario Saric Maintained (BN) at Buy with Increased Target to $51 on, Aug 1st, 2024

by: WOPRAI

Joseph Pantginis Reiterated (BMEA) at Strong Buy and Held Target at $15 on, Aug 1st, 2024

by: WOPRAI

Jade Rahmani Maintained (CBRE) at Hold with Increased Target to $120 on, Aug 1st, 2024

by: WOPRAI

David Tarantino Maintained (CAKE) at Hold with Increased Target to $40 on, Aug 1st, 2024

by: WOPRAI

Jim Salera Reiterated (CAKE) at Buy and Held Target at $50 on, Aug 1st, 2024

by: WOPRAI

Zachary Fadem Maintained (CAKE) at Hold with Increased Target to $38 on, Aug 1st, 2024

by: WOPRAI

Jeffrey Bernstein Maintained (CAKE) at Sell with Increased Target to $35 on, Aug 1st, 2024

by: WOPRAI

Brian Mullan Maintained (CAKE) at Hold with Increased Target to $39 on, Aug 1st, 2024

by: WOPRAI

Nick Setyan Reiterated (CAKE) at Buy and Held Target at $45 on, Aug 1st, 2024

by: WOPRAI

Moshe Orenbuch Maintained (CACC) at Strong Sell with Decreased Target to $400 on, Aug 1st, 2024

by: WOPRAI

Damon Delmonte Maintained (CAC) at Hold with Increased Target to $40 on, Aug 1st, 2024

by: WOPRAI

Bernie McTernan Maintained (COMP) at Strong Buy with Increased Target to $6 on, Aug 1st, 2024

by: WOPRAI

Tobey Sommer Maintained (CCRN) at Hold with Increased Target to $17 on, Aug 1st, 2024

by: WOPRAI

Yi Chen Reiterated (CDNA) at Hold on, Aug 1st, 2024

by: WOPRAI

Connor Chamberlain Maintained (CDNA) at Strong Buy with Increased Target to $32 on, Aug 1st, 2024

by: WOPRAI

Matthew Sykes Maintained (CDNA) at Strong Buy with Increased Target to $26 on, Aug 1st, 2024

by: WOPRAI

Mark Moskowitz Maintained (CDW) at Hold with Decreased Target to $229 on, Aug 1st, 2024

by: WOPRAI

Bobby Brooks Maintained (CECO) at Buy with Increased Target to $35 on, Aug 1st, 2024

by: WOPRAI

Chris Carey Maintained (SMG) at Buy with Increased Target to $85 on, Aug 1st, 2024

by: WOPRAI

Peter Keith Maintained (SNBR) at Hold with Decreased Target to $12 on, Aug 1st, 2024

by: WOPRAI

Mike Matson Maintained (SYK) at Strong Buy with Increased Target to $393 on, Aug 1st, 2024

by: WOPRAI

Richard Newitter Maintained (SYK) at Hold with Decreased Target to $345 on, Aug 1st, 2024

by: WOPRAI

Matt Miksic Maintained (SYK) at Buy with Increased Target to $402 on, Aug 1st, 2024

by: WOPRAI

Andrew Fein Reiterated (SYRS) at Strong Buy and Held Target at $15 on, Aug 1st, 2024

Tobey Sommer Maintained (CCRN) at Hold with Increased Target to $17 on, Aug 1st, 2024

Tobey Sommer of Truist Securities, Maintained "Cross Country Healthcare, Inc." (CCRN) at Hold with Increased Target from $16 to $17 on, Aug 1st, 2024.

Tobey has made no other calls on CCRN in the last 4 months.



There are 2 other peers that have a rating on CCRN. Out of the 2 peers that are also analyzing CCRN, 0 agree with Tobey's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Tobey

  • Kevin Steinke of "Barrington Research" Maintained at Buy with Decreased Target to $21 on, Monday, May 6th, 2024
  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $19 on, Thursday, May 2nd, 2024

Like: 👍